Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Cancer Vaccines01:30

Cancer Vaccines

960
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
960

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cuproptosis-immunity crosstalk informs strategy to overcome immunotherapy resistance.

Cell·2026
Same author

Artificial Intelligence in Image Assisted Radiation Oncology.

Cancers·2026
Same author

The Quiet Neck in Esthesioneuroblastoma.

International journal of radiation oncology, biology, physics·2026
Same author

Defining the Role of SABR in Head and Neck Cancer: Results From a Multi-institutional Delphi Consensus.

International journal of radiation oncology, biology, physics·2026
Same author

Understanding the Symptom Burden of Complex Skull Base Tumors From the Patient's Perspective.

Head & neck·2026
Same author

Outcomes of different treatment patterns for adenoid cystic carcinoma of the anterior craniofacial area: A multi-institutional study on 578 patients.

European journal of cancer (Oxford, England : 1990)·2026
Same journal

Comment on "Hippocampal Avoidance During Prophylactic Cranial Irradiation for Patients With Small Cell Lung Cancer: Randomized Phase II/III Trial NRG-CC003".

Practical radiation oncology·2026
Same journal

In Reply to Chhabra et al.

Practical radiation oncology·2026
Same journal

In Reply to Sidhu and Beriwal.

Practical radiation oncology·2026
Same journal

In Regard to Jimenez et al.

Practical radiation oncology·2026
Same journal

Trust: A Lesson in Truth.

Practical radiation oncology·2026
Same journal

PROshot: Proton Therapy for Head and Neck Cancer, Hypofractionated Head and Neck Radiation, Radiosurgery Versus Hippocampal Avoidance, and Androgen Deprivation Therapy in the Salvage Setting.

Practical radiation oncology·2026
See all related articles

Related Experiment Video

Updated: Jan 15, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.9K

Real-World Guide for Delivering Immunotherapy With Radiation Therapy.

Denton J Robinson1, Hampartsoum B Barsoumian1, Ansel P Nalin1

  • 1Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.

Practical Radiation Oncology
|October 8, 2025
PubMed
Summary
This summary is machine-generated.

Optimizing immunoradiation therapy (radiation therapy + immunotherapy) improves cancer treatment outcomes. Tailoring protocols based on patient factors and sequencing enhances local and systemic tumor control for better patient response.

More Related Videos

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.7K
PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator
10:48

PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator

Published on: December 28, 2017

9.9K

Related Experiment Videos

Last Updated: Jan 15, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.9K
Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.7K
PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator
10:48

PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator

Published on: December 28, 2017

9.9K

Area of Science:

  • Oncology
  • Radiation Oncology
  • Immunotherapy

Background:

  • Radiation therapy (RT) is a cornerstone of cancer care but faces limitations due to tumor resistance.
  • Immunotherapy enhances the immune system's ability to fight cancer, complementing RT.
  • Immunoradiation therapy combines RT and immunotherapy for improved tumor control and patient response.

Purpose of the Study:

  • To provide a practical guide for optimizing immunoradiation therapy in clinical settings.
  • To bridge the gap between research findings and clinical application of combined RT and immunotherapy.
  • To synthesize current literature and clinical experience for effective treatment strategies.

Main Methods:

  • Review of current literature and clinical experience on integrating immunotherapy and RT.
  • Focus on pretreatment factors, immunotherapy sequencing, RT planning, and follow-up.
  • Consideration of radiation dosing, fractionation, tumor size, organs at risk, and monitoring.

Main Results:

  • Combined RT and immunotherapy enhance local tumor control and systemic immune activation.
  • Key factors influencing outcomes include prior chemotherapy, steroid use, lymphocyte counts, and RT/immunotherapy sequencing.
  • Strategies like pulsed RT and lymphocyte-sparing techniques are important for managing progression.

Conclusions:

  • Tailoring immunoradiation therapy based on key influencing factors improves therapeutic outcomes.
  • Integration of artificial intelligence and multidisciplinary coordination advances treatment precision.
  • Personalized care in clinical oncology is enhanced through optimized immunoradiation protocols.